The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.

MLA

Ghebrehiwet, Berhane, et al. “The C1q and GC1qR Axis as a Novel Checkpoint Inhibitor in Cancer.” Frontiers in Immunology, May 2024, pp. 01–09. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1351656.

APA

Ghebrehiwet, B., Zaniewski, M., Fernandez, A., DiGiovanni, M., Reyes, T. N., Ping Ji, Savitt, A. G., Williams, J. L., Seeliger, M. A., & Peerschke, E. I. B. (2024). The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer. Frontiers in Immunology, 01–09. https://doi.org/10.3389/fimmu.2024.1351656

Chicago

Ghebrehiwet, Berhane, Michal Zaniewski, Audrey Fernandez, Mathew DiGiovanni, Tiana N. Reyes, Ping Ji, Anne G. Savitt, Jennie L. Williams, Markus A. Seeliger, and Ellinor I. B. Peerschke. 2024. “The C1q and GC1qR Axis as a Novel Checkpoint Inhibitor in Cancer.” Frontiers in Immunology, May, 01–09. doi:10.3389/fimmu.2024.1351656.